安全网公立医院实施当日乳腺活检项目的效果
该研究采用中断时间序列设计,评估安全网医院实施当日乳腺活检(SDB)项目对从活检推荐到活检时间的影响。共纳入677例接受超声引导下乳腺活检的患者,结果显示SDB项目将活检推荐至活检的中位时间从13.0天降至3.5天(P < .0001),但从活检推荐至初次外科或肿瘤科预约的时间无统计学显著下降。
要点
- 安全网医院实施当日乳腺活检项目可缩短活检等待时间。
- 活检推荐至活检的中位时间从13.0天降至3.5天(P < .0001)。
- 活检推荐至外科或肿瘤科预约时间无统计学显著变化。
核心结论
- 实施当日乳腺活检项目能有效减少安全网机构中乳腺活检推荐后的整体诊断延迟,但可能需要额外的行政和辅助支持以进一步改善治疗时间。
研究设计与样本
- 中断时间序列设计,包含实施前和实施后分析;共纳入677例接受超声引导下乳腺活检的患者,分为导入期组233例、正式实施期组306例和随访期组138例;研究经机构审查委员会批准。
临床应用与阅片要点
- 作者认为,在安全网机构中实施当日乳腺活检项目可有效减少活检推荐后的诊断延迟;但可能需要额外的行政和辅助支持来帮助外科和肿瘤科服务,以进一步改善这些环境下的整体治疗时间。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Safety-net hospitals play an important role in providing care to patients from historically underserved groups, representing a natural target for initiatives to reduce health disparities. This study evaluates the implementation of a same-day biopsy (SDB) program on time to breast biopsy in the safety-net setting.
MATERIALS AND METHODS: This study used an interrupted time series design with pre- and postanalysis. After institutional review board approval, all diagnostic and ultrasound (US) examinations leading to US-guided biopsy during the phase-in period (May 2021 to February 2022), official implementation period (March 2022 to April 2023), and follow-up period (May 2023 to December 2023) were identified. Demographic characteristics of the groups using Wilcoxon rank-sum tests for continuous variables in χ2 tests of independence for categorical variables were evaluated. Spline modeling with generalized linear models was used to assess differences in days from biopsy recommendation to biopsy and rates of having a SDB in pre- and postimplementation groups.
RESULTS: A total of 677 patients received recommended US-guided breast biopsies during the study period, with 233 patients in the phase-in group, 306 patients in the official implementation group, and 138 patients in the follow-up group. For all patients, the SDB program reduced the median time from biopsy recommendation to biopsy from 13.0 to 3.5 (interquartile range: 6.0-12.0) days (P < .0001). There was no statistically significant decrease in time from biopsy recommendation to initial surgical (19.0-15.0 days; P = .29) or oncologic (26.0-21.0 days; P = .19) appointment.
CONCLUSION: Implementation of a SDB program is effective in reducing overall diagnostic delays after a breast biopsy recommendation for patients seen in safety-net institutions. Additional administrative and ancillary support may be required, however, to aid surgical and oncologic services to further improve overall time to treatment in these settings.
引用
- Tran NT, Ewald I, Baird GL, et al. Outcomes of Implementation of a Same-Day Breast Biopsy Program in a Safety-Net Public Hospital. J Am Coll Radiol. 2025. PMID: 40311772. doi:10.1016/j.jacr.2025.04.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。